General Info
Beat Steffen is a Managing Director at Novartis Venture Fund in Basel, Switzerland. He focuses on investing in life science companies developing biotechnology and biopharmaceutical therapeutics to address unmet patient needs. His previous investments include companies like Rappta, SpliceBio, Vivet Therapeutics, FoRx Therapeutics, and UZH Life Sciences Fund.
Location:
Country: Switzerland
Industries: biotechnology, biopharmaceuticals, healthcare
Investment Regions: EU
Investment Stages: pre-seed, seed
Website: https://www.nvfund.com/#OurTeam
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search results show Beat Steffen is listed as Managing Director at Novartis Venture Fund and a Novartis NVF LinkedIn post and SpliceBio press release from June 11, 2025 indicate NVF participation; SpliceBio secured Series B financing on June 11, 2025, which is less than 6 months before the reference date, indicating recent investment activity (SpliceBio). Therefore tag is very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Beat Steffen
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI